Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.64+0.14 (+1.87%)
Close on Nov 13, 2026Market cap $459.08MP/E –Yield –
Oculis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oculis's enterprise value was $322.36M on Nov 11, 2026, against $687.75M a year earlier. Over the last 5 years it ranged from -$25.34M to $1.33B, with a median of $314.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $322.36M | -55.6% |
| 2025 | Dec 31, 2025 | $725.94M | +57.8% |
| 2024 | Dec 31, 2024 | $459.94M | +3025.1% |
| 2023 | Dec 29, 2023 | $14.72M | – |
| 2022 | Dec 30, 2022 | -$22.02M | -212.5% |
| 2021 | Dec 31, 2021 | $19.58M | – |
See a number that looks wrong?